EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
+6.82%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$397M
AUM Growth
+$14.8M
(+3.9%)
Cap. Flow
+$3.92M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Ligand Pharmaceuticals
LGND
|
+$3.92M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 94.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $158M | 39.93% |
1,450,000
| – | – |
|
|
ENTL
2
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $69.7M | 17.55% |
3,813,197
| – | – |
|
|
RVNC
3
DELISTED
Revance Therapeutics, Inc.
RVNC
| $62.5M | 15.74% |
4,592,047
| – | – |
|
4
Axogen
AXGN
$770M
| $33.4M | 8.43% |
4,861,111
| – | – |
|
|
CORI
5
DELISTED
Corium International, Inc.
CORI
| $32.5M | 8.18% |
9,353,304
| – | – |
|
|
ELGX
6
DELISTED
Endologix Inc
ELGX
| $22.2M | 5.59% |
125,747
| – | – |
|
7
MediciNova
MNOV
$61.3M
| $8.84M | 2.23% |
1,170,370
| – | – |
|
|
8
Ligand Pharmaceuticals
LGND
$3.24B
| $3.92M | 0.99% |
+52,727
| New | +$3.92M |
|
|
ACUR
9
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $3.62M | 0.91% |
1,956,397
| – | – |
|
10
Gyre Therapeutics
GYRE
$689M
| $1.82M | 0.46% |
10,483
| – | – |
|